Atherosclerotic vascular disease in the autoimmune rheumatologic patient

Rekha Mankad1

  • 1Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA, mankad.rekha@mayo.edu.

Insights

Autoimmune diseases significantly increase the risk of atherosclerotic cardiovascular diseases (ASCVD), especially in women. Recognizing this link and inflammation

Area of Science:

  • Rheumatology
  • Immunology
  • Cardiology

Background:

  • Autoimmune diseases like rheumatoid arthritis and lupus are linked to higher atherosclerotic cardiovascular diseases (ASCVD) risk.
  • Women are disproportionately affected by autoimmune conditions and have higher cardiovascular mortality, highlighting a critical gender-specific risk.
  • Inflammation and immune dysregulation are shared mechanisms underlying both autoimmune conditions and atherosclerosis.

Purpose of the Study:

  • To explore the heightened cardiovascular risk in patients with autoimmune diseases.
  • To investigate the role of inflammation and immune mechanisms in ASCVD development within this population.
  • To address the under-recognition of cardiovascular risk in autoimmune patients and the limitations of current risk assessment tools.

Main Methods:

  • Literature review and synthesis of existing research on autoimmune diseases and cardiovascular outcomes.
  • Analysis of the interplay between inflammatory pathways, immune responses, and atherogenesis.
  • Examination of the performance of traditional cardiovascular risk algorithms in autoimmune populations.

Main Results:

  • Autoimmune diseases are associated with a substantially increased risk of ischemic heart disease (IHD) and other ASCVDs.
  • Current cardiovascular risk prediction models inadequately capture the elevated risk in patients with autoimmune conditions.
  • Inflammation is a key driver of atherosclerosis in autoimmune disease, contributing to cardiovascular risk beyond traditional factors.

Conclusions:

  • There is a critical need to improve awareness and recognition of elevated cardiovascular risk among autoimmune patients and healthcare providers.
  • Novel risk assessment strategies incorporating inflammatory markers are needed for the autoimmune population.
  • Understanding the shared inflammatory pathways is crucial for developing targeted prevention and treatment strategies for cardiovascular disease in autoimmune conditions.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
975
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
2.3K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.2K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
821
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
613
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.2K